NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (" NurExone " or the " Company "), a biopharmaceutical company developing exosome-based regenerative therapies, is pleased to announce ...

Acute Flaccid Myelitis (AFM) is an uncommon but severe neurological disorder that causes sudden paralysis in children.

Researchers at Kennedy Krieger Institute's International Center for Spinal Cord Injury (ICSCI) have made a remarkable ...

Researchers at Kennedy Krieger Institute's International Center for Spinal Cord Injury (ICSCI) have made a remarkable advancement in treating children with Acute Flaccid Myelitis (AFM), a rare but ...

Researchers at Kennedy Krieger Institute report that Transcutaneous Spinal Cord Stimulation (TSS) combined with movement ...

That impact left Diane Lundmark, an active bicyclist and former adaptive volunteer ski instructor at Allina Health Courage ...

and subacute (those who are closer to their time of injury), given demonstrated efficacy in preclinical models of both chronic and acute spinal cord injury. The trial is designed to evaluate the ...

Concurrently with these guidelines, NASS developed Appropriate Use Criteria to determine appropriate (or reasonable) ...

[2] Spinal cord compression constitutes a true emergency because the initial injury to the spinal cord ... patients with this complication in the acute care setting, particularly in an acute ...

It supports players at any level of the game who have sustained a life-changing injury such as a catastrophic spinal cord or acute, severe traumatic brain injury while playing rugby union in England.

BALTIMORE, November 12, 2024— Researchers at Kennedy Krieger Institute's International Center for Spinal Cord Injury (ICSCI) have made a remarkable advancement in treating children with Acute Flaccid ...